and evaluate a new strategy to enhance cell death responses to BRAF/MEK inhibitors in pre-clinical models MRA Young Investigator Award, 2017-2020 Rizwan Haq, Dana-Farber Cancer Institute Overcome resistance to PD1 blockade by adding oncolytic virus TVEC: Will analyze cellular and genomic changes in tumo